Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IMVT-1402
IMVT-1402
Immunovant shares surge as early antibody treatment data beats expectations
Yahoo/Reuters
Tue, 09/26/23 - 11:43 am
Roivant
Immunovant
antibodies
clinical trials
IMVT-1402
autoimmune diseases
Immunovant Shares Touch 52-Week High After FDA Green Lights IMVT-1402 Study
Marketwatch
Tue, 05/23/23 - 10:12 am
Immunovant
immunology
IMVT-1402
autoimmune disease
FDA